Age 19 and more
On dual or triple antiplatelet therapy and between 12months and 14months from Bioresorbable Vascular Scaffold implantation
No history of death, serious myocardial infarction, stroke, repeat revascularization, or major bleeding

NCT02939872_inc_T1
Person
Age
NCT02939872_inc_T2
Value
19 and more
NCT02939872_inc_T3
Procedure
triple antiplatelet therapy
NCT02939872_inc_T4
Procedure
ual ntiplatelet therapy
NCT02939872_inc_T5
Temporal
between 12months and 14months from Bioresorbable Vascular Scaffold implantation
NCT02939872_inc_T6
Device
Bioresorbable Vascular Scaffold
NCT02939872_inc_T7
Procedure
implantation
NCT02939872_inc_T8
Reference_point
Bioresorbable Vascular Scaffold implantation
NCT02939872_inc_T9
Scope
dual or triple antiplatelet therapy
NCT02939872_inc_T10
Negation
No
NCT02939872_inc_T11
Observation
history
NCT02939872_inc_T12
Condition
death
NCT02939872_inc_T13
Qualifier
serious
NCT02939872_inc_T14
Condition
myocardial infarction
NCT02939872_inc_T15
Condition
stroke
NCT02939872_inc_T16
Multiplier
repeat
NCT02939872_inc_T17
Procedure
revascularization
NCT02939872_inc_T18
Qualifier
major
NCT02939872_inc_T19
Condition
bleeding
NCT02939872_inc_T20
Scope
death, serious myocardial infarction, stroke, repeat revascularization, or major bleeding